Please login to the form below

Not currently logged in
Email:
Password:

basil insulin lispro

This page shows the latest basil insulin lispro news and features for those working in and with pharma, biotech and healthcare.

Lilly delays filing of Lantus rival on safety concerns

Lilly delays filing of Lantus rival on safety concerns

Eli Lilly has reined in plans to topple Sanofi's Lantus from the head of the long-acting insulin market after delaying regulatory filings for its insulin peglispro in the EU ... Lilly has said it will now file for approval of basil insulin lispro (BIL),

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics